Rhenman & Partners Asset Management Ab Glaukos Corp Transaction History
Rhenman & Partners Asset Management Ab
- $1.01 Billion
- Q2 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Glaukos Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 50,000 shares of GKOS stock, worth $6.61 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
50,000
Previous 27,000
85.19%
Holding current value
$6.61 Million
Previous $2.55 Million
132.5%
% of portfolio
0.58%
Previous 0.25%
Shares
26 transactions
Others Institutions Holding GKOS
# of Institutions
307Shares Held
46.8MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$721 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$251 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$246 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$214 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.29B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...